LncRNA SNHG14 regulates the DDP-resistance of non-small cell lung cancer cell through miR-133a/HOXB13 pathway
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LncRNA SNHG14 regulates the DDP-resistance of non-small cell lung cancer cell through miR-133a/HOXB13 pathway
Authors
Keywords
-
Journal
BMC Pulmonary Medicine
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-10-15
DOI
10.1186/s12890-020-01276-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SNHG14 enhances gemcitabine resistance by sponging miR-101 to stimulate cell autophagy in pancreatic cancer
- (2019) Xiufeng Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- SNHG14 confers gefitinib resistance in non-small cell lung cancer by up-regulating ABCB1 via sponging miR-206-3p
- (2019) Kai Wu et al. BIOMEDICINE & PHARMACOTHERAPY
- SNHG14 silencing suppresses the progression and promotes cisplatin sensitivity in non-small cell lung cancer
- (2019) Pengfei Jiao et al. BIOMEDICINE & PHARMACOTHERAPY
- The long non-coding RNA SNHG14 inhibits cell proliferation and invasion and promotes apoptosis by sponging miR-92a-3p in glioma
- (2018) Qiang Wang et al. Oncotarget
- Role of long non-coding RNA in drug resistance in non-small cell lung cancer
- (2018) Leirong Wang et al. Thoracic Cancer
- Long non-coding RNA SNHG14 exerts oncogenic functions in non-small cell lung cancer through acting as a miR-340 sponge
- (2018) Zhenhua Zhang et al. BIOSCIENCE REPORTS
- Long non-coding RNA SNHG14 induces trastuzumab resistance of breast cancer via regulating PABPC1 expression through H3K27 acetylation
- (2018) Huaying Dong et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- LncRNA SNHG14 promotes the progression of cervical cancer by regulating miR-206/YWHAZ
- (2018) Nannan Ji et al. PATHOLOGY RESEARCH AND PRACTICE
- Uncommon EGFR mutations in advanced non-small cell lung cancer
- (2017) Grainne M. O’Kane et al. LUNG CANCER
- The role of microRNAs in the pathophysiology of adrenal tumors
- (2017) Nunki Hassan et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Lung cancer epigenetics: From knowledge to applications
- (2017) Michaël Duruisseaux et al. SEMINARS IN CANCER BIOLOGY
- MicroRNA in cardiovascular biology and disease
- (2017) Anna Wojciechowska et al. Advances in Clinical and Experimental Medicine
- MiR-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway
- (2017) Chao Fang et al. Scientific Reports
- LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression
- (2017) Zheng Fang et al. Cancer Medicine
- The role of microRNAs in resistance to targeted treatments of non-small cell lung cancer
- (2016) Hongjing Zang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancer
- (2016) D.A. Fennell et al. CANCER TREATMENT REVIEWS
- RmiR-133a enhances the sensitivity of Hep-2 cells and vincristine-resistant Hep-2v cells to cisplatin by downregulating ATP7B expression
- (2016) XURUI WANG et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Molecular pathways and therapeutic targets in lung cancer
- (2015) Emma Shtivelman et al. Oncotarget
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- MicroRNA-133a Suppresses Multiple Oncogenic Membrane Receptors and Cell Invasion in Non-Small Cell Lung Carcinoma
- (2014) Lu-Kai Wang et al. PLoS One
- Systems biology of cisplatin resistance: past, present and future
- (2014) L Galluzzi et al. Cell Death & Disease
- Activation of ERK1/2 and Akt is associated with cisplatin resistance in human lung cancer cells
- (2013) Mei Wang et al. JOURNAL OF CHEMOTHERAPY
- HOXB13 downregulates intracellular zinc and increases NF-κB signaling to promote prostate cancer metastasis
- (2013) Y-R Kim et al. ONCOGENE
- miR-133a suppresses cell proliferation, migration and invasion in human lung cancer by targeting MMP-14
- (2013) MENG XU et al. ONCOLOGY REPORTS
- Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
- (2008) Jean-Pierre Pignon et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search